Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)

17h ago, source: Yahoo Finance

On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd (NYSE:BHVN), purchased 25,503 shares of the company, as reported ...

RBC Capital Keeps Their Buy Rating on Biohaven Ltd. (BHVN)

17h ago, source:

RBC Capital analyst Leonid Timashev maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report) today and set a price target of ...

Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

4d ago, source: Stockhouse

NEW HAVEN, Conn., April 22, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key ...

Buy Rating Affirmed for Biohaven Ltd. Amid Positive Clinical Outlook and Pipeline Potential

11d ago, source:

J.P. Morgan analyst Tessa Romero has maintained their bullish stance on BHVN stock, giving a Buy rating yesterday. Tessa Romero has given his ...

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares

7d ago, source:

Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, ...

Biohaven Stock (NYSE:BHVN), Analyst Ratings, Price Targets, Predictions

3d ago, source: Benzinga.com

There is no last upgrade for Biohaven.

Biohaven hits an all-time high after R&D Day

10mon ago, source: Hosted on MSN

Shares of Biohaven Ltd. (NYSE:BHVN) added ~14% to reach an all-time high on Thursday following three straight sessions of gains, a day after the neuro-pharmaceutical drug developer conducted its R ...

Biohaven Ltd.

3mon ago, source: CNN

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and ...

Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock

1mon ago, source:

In the last year, multiple insiders have substantially increased their holdings of Biohaven Ltd. ( NYSE:BHVN ) ...

Biohaven Announces Pricing of $230 Million Public Offering of Common Shares

8d ago, source: The Victoria Advocate

NEW HAVEN, Conn., April 18, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN), a biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments ...

Biohaven Ltd BHVN

11d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...